ProShares Ultra Nasdaq Biotechnology (BIB) |
| 63.8319 -1.808 (-2.75%) 10-10 16:00 |
| Open: | 65.075 |
| High: | 65.28 |
| Low: | 63.6212 |
| Volume: | 17,796 |
| Market Cap: | 56(M) |
| PE Ratio: | 21.53 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 77.51 |
| Resistance 1: | 66.36 |
| Pivot price: | 61.25 |
| Support 1: | 59.55 |
| Support 2: | 55.34 |
| 52w High: | 68 |
| 52w Low: | 33.78 |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 24 Sep 2025
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Raises Dividend to $0.18 Per Share - MarketBeat
Mon, 22 Sep 2025
Toth Financial Advisory Corp Decreases Stock Holdings in ProShares Ultra Nasdaq Biotechnology $BIB - beritasriwijaya.co.id
Thu, 22 Feb 2024
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 - InvestorPlace
Fri, 14 Apr 2023
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering and Biotechnology News
Wed, 22 Dec 2021
Top Biotechnology Indexes in the U.S. and How to Invest in Them - Nasdaq
Mon, 13 Dec 2021
atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index - Psychedelic Alpha
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
